Shailesh Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 04-12-2024
- Paid Up Capital ₹ 0.30 M
as on 04-12-2024
- Company Age 26 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.78 M
as on 04-12-2024
- Satisfied Charges ₹ 1.10 M
as on 04-12-2024
- Revenue 35.60%
(FY 2022)
- Profit 9.33%
(FY 2022)
- Ebitda 41.09%
(FY 2022)
- Net Worth 7.96%
(FY 2022)
- Total Assets -4.52%
(FY 2022)
About Shailesh Pharmaceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹2.78 M. The company has closed loans amounting to ₹1.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shailesh Sharma, Gauri Sharma, and Virbala Sharma serve as directors at the Company.
- CIN/LLPIN
U24232UP1998PTC023277
- Company No.
023277
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Mar 1998
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- LocationUttar Pradesh, Uttar Pradesh
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Shailesh Pharmaceuticals Private Limited offer?
Shailesh Pharmaceuticals Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Pain Relief Oil, Ayurvedic Herbal Syrups & Tonics, Ayurvedic Immunity Booster, Ayurvedic & Herbal Health Supplement, Herbal Juice.
Who are the key members and board of directors at Shailesh Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shailesh Sharma  | Director | 26-Mar-1998 | Current |
| Gauri Sharma | Director | 26-Mar-1998 | Current |
| Virbala Sharma | Director | 23-Jun-2003 | Current |
Financial Performance of Shailesh Pharmaceuticals.
Shailesh Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 35.6% increase. The company also saw a slight improvement in profitability, with a 9.33% increase in profit. The company's net worth moved up by a moderate rise of 7.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shailesh Pharmaceuticals?
In 2020, Shailesh Pharmaceuticals had a promoter holding of 96.33% and a public holding of 3.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 11 Nov 2021 | ₹0.28 M | Open |
Canara Bank Creation Date: 20 Sep 1999 | ₹2.50 M | Open |
Canara Bank Creation Date: 09 Jun 2020 | ₹0.48 M | Satisfied |
How Many Employees Work at Shailesh Pharmaceuticals?
Unlock and access historical data on people associated with Shailesh Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shailesh Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shailesh Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
